Aminocaproic Acid

Product manufactured by Hospira, Inc.

Application Nr Approved Date Route Status External Links
ANDA070010 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Aminocaproic Acid Injection, Is Useful In Enhancing Hemostasis When Fibrinolysis Contributes To Bleeding. In Life-Threatening Situations, Fresh Whole Blood Transfusions, Fibrinogen Infusions, And Other Emergency Measures May Be Required. Fibrinolytic Bleeding May Frequently Be Associated With Surgical Complications Following Heart Surgery (With Or Without Cardiac Bypass Procedures), And Portacaval Shunt; Hematological Disorders Such As Aplastic Anemia; Acute And Life-Threatening Abruptio Placentae; Hepatic Cirrhosis; And Neoplastic Disease Such As Carcinoma Of The Prostate, Lung, Stomach, And Cervix. Urinary Fibrinolysis, Usually A Normal Physiological Phenomenon, May Frequently Be Associated With Life-Threatening Complications Following Severe Trauma, Anoxia, And Shock. Symptomatic Of Such Complications Is Surgical Hematuria (Following Prostatectomy And Nephrectomy) Or Nonsurgical Hematuria (Accompanying Polycystic Or Neoplastic Diseases Of The Genitourinary System). (See Warnings .)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Aminocaproic Acid

Comments